COMP <GO>
CBLL vs INMD // FREE CASH FLOW YIELD
CeriBell Inc. (NASDAQ) VS. InMode Ltd. (NASDAQ) • 15-METRIC TALLY: CBLL 5
— INMD 3
▲ FREE CASH FLOW YIELD LEADER: INMD
LAST: $26.58 (-4.46%) • MKT CAP: $1.07B
fcf-yield
-3.89%
LAST: $13.22 (-2.15%) • MKT CAP: $776.6M
fcf-yield
10.85%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CBLL VS. INMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CBLL | INMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 87.90% | 78.50% | +9.40 | CBLL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 17.70% | -52.70 | INMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 5.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -3.89% | 10.85% | -14.74 | INMD | /fcf-yield <GO> |
| Operating Margin | -60.00% | 23.00% | -83.00 | INMD | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 36.10% | -6.20% | +42.30 | CBLL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 14.75 | 9.20 | +5.55 | CBLL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.9 | 36.3 | +23.60 | CBLL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.07B | $776.6M | $291.1M | CBLL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CBLL REV | INMD REV | CBLL GROSS % | INMD GROSS % | CBLL FCF | INMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $89.1M | $370.5M | 87.9% | 78.5% | -$41.6M | $84.3M |
| FY 2024 | $65.4M | $394.8M | 86.7% | 80.3% | -$36.4M | $132.0M |
| FY 2023 | $45.2M | $492.0M | — | — | -$29.2M | $176.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CBLL // BETA —
INMD // BETA —